Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

Six Action Steps to Address Global Disparities in Parkinson Disease

Nicoline SchiessBrain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, SwitzerlandRodrigo CataldiBrain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, SwitzerlandMichael S. OkunAssociate Editor, JAMA NeurologyNatasha Fothergill‐MisbahDepartment of Gerontology, University of Southampton, Southampton, United KingdomE. Ray DorseyUniversity of Rochester, Rochester, New YorkBastiaan R. BloemDonders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, the NetherlandsMaria BarrettoParkinson’s Disease and Movement Disorder Society, Mumbai, IndiaRoongroj BhidayasiriChulalongkorn Centre of Excellence for Parkinson’s Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, ThailandR. J. BrownChemical Safety and Health Unit, Department of Environment, Climate Change and Health, World Health Organization, Geneva, SwitzerlandLorraine ChishimbaUniversity Teaching Hospital, Lusaka, ZambiaNeerja ChowdharyBrain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, SwitzerlandMax CoslovEdmond J. Safra Foundation, Geneva, SwitzerlandEsther CuboHospital Universitario Burgos, Burgos, SpainAlessandro Di RoccoZucker School of Medicine at Hofstra Northwell, Uniondale, New YorkRachel DolhunThe Michael J. Fox Foundation, New York, New YorkChristopher DowrickUniversity of Liverpool, Liverpool, United KingdomVictor S.C. FungWestmead HospitalOscar S. GershanikInstitute of Neuroscience, Favaloro Foundation University Hospital, Buenos Aires, ArgentinaLarry GiffordJoyce GordonHanan KhalilCollege of Health Sciences, Department of Physiotherapy, Qatar University, Doha, QatarAndrea A. KühnDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, GermanySara LewMalaysian Parkinson’s Disease Association, Kuala Lumpur, MalaysiaShen‐Yang LimDivision of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaMaria MaranoJacquie MicallefJolynne MokayaUniversity of Oxford, Oxford, United KingdomEmile MoukheiberDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MarylandLynda NwabuobiWeill Cornell Parkinson’s Disease and Movement Disorders Institute, New York, New YorkNjideka OkubadejoCollege of Medicine, University of Lagos, Lagos, NigeriaPramod Kumar PalNational Institute of Mental Health and Neurosciences, Bengaluru, IndiaHiral ShahColumbia University Medical Center, New York, New YorkAli ShalashDepartment of Neurology, Faculty of Medicine, Ain Shams University, Cairo, EgyptTodd ShererThe Michael J. Fox Foundation, New York, New YorkBernadette SiddiquiThe Michael J. Fox Foundation, New York, New YorkTed ThompsonThe Michael J. Fox Foundation, New York, New YorkAndreas UllrichDepartment of Gynaecology and Gynaecological Oncology Neurology, Charité-Universitätsmedizin Berlin, Berlin, GermanyRichard WalkerNorthumbria Healthcare NHS Foundation Trust, Newcastle-upon-Tyne, United KingdomTarun DuaBrain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland
2022en
ABI

Аннотация

Importance: The Global Burden of Disease study conducted between 1990 and 2016, based on a global study of 195 countries and territories, identified Parkinson disease (PD) as the fastest growing neurological disorder when measured using death and disability. Most people affected by PD live in low- and middle-income countries (LMICs) and experience large inequalities in access to neurological care and essential medicines. This Special Communication describes 6 actions steps that are urgently needed to address global disparities in PD. Observations: The adoption by the 73rd World Health Assembly (WHA) of resolution 73.10 to develop an intersectoral global action plan on epilepsy and other neurological disorders in consultation with member states was the stimulus to coordinate efforts and leverage momentum to advance the agenda of neurological conditions, such as PD. In April 2021, the Brain Health Unit at the World Health Organization convened a multidisciplinary, sex-balanced, international consultation workshop, which identified 6 workable avenues for action within the domains of disease burden; advocacy and awareness; prevention and risk reduction; diagnosis, treatment, and care; caregiver support; and research. Conclusions and Relevance: The dramatic increase of PD cases in many world regions and the potential costs of PD-associated treatment will need to be addressed to prevent possible health service strain. Across the board, governments, multilateral agencies, donors, public health organizations, and health care professionals constitute potential stakeholders who are urged to make this a priority.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0